Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 8.45494895 |
2 | Golgi transport vesicle coating (GO:0048200) | 8.45494895 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 8.14044459 |
4 | signal peptide processing (GO:0006465) | 7.56136570 |
5 | protein retention in ER lumen (GO:0006621) | 7.11703311 |
6 | protein maturation by protein folding (GO:0022417) | 5.87921343 |
7 | exocrine pancreas development (GO:0031017) | 5.52380451 |
8 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.32919914 |
9 | positive regulation of nuclease activity (GO:0032075) | 5.26562558 |
10 | sequestering of metal ion (GO:0051238) | 5.11689222 |
11 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 5.09086200 |
12 | COPII vesicle coating (GO:0048208) | 5.01127589 |
13 | regulation of nuclease activity (GO:0032069) | 4.91323200 |
14 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.76811652 |
15 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.70036576 |
16 | cellular response to unfolded protein (GO:0034620) | 4.64142989 |
17 | proteasome assembly (GO:0043248) | 4.64029605 |
18 | cellular response to topologically incorrect protein (GO:0035967) | 4.49945838 |
19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.48468223 |
20 | protein N-linked glycosylation via asparagine (GO:0018279) | 4.43979221 |
21 | peptidyl-asparagine modification (GO:0018196) | 4.38786522 |
22 | ER-nucleus signaling pathway (GO:0006984) | 4.38638224 |
23 | GDP-mannose metabolic process (GO:0019673) | 4.21368209 |
24 | response to endoplasmic reticulum stress (GO:0034976) | 4.09057311 |
25 | protein N-linked glycosylation (GO:0006487) | 4.06900897 |
26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06422687 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06422687 |
28 | DNA deamination (GO:0045006) | 4.04507639 |
29 | ribosomal small subunit biogenesis (GO:0042274) | 4.03958966 |
30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.92950636 |
31 | proline biosynthetic process (GO:0006561) | 3.72077204 |
32 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.69587075 |
33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.69307656 |
34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.68227427 |
35 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.65339230 |
36 | ATP synthesis coupled proton transport (GO:0015986) | 3.63504223 |
37 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.63504223 |
38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.61769985 |
39 | response to unfolded protein (GO:0006986) | 3.56544094 |
40 | protein targeting to ER (GO:0045047) | 3.55406071 |
41 | regulation of mitochondrial translation (GO:0070129) | 3.55270651 |
42 | ER overload response (GO:0006983) | 3.53819444 |
43 | pseudouridine synthesis (GO:0001522) | 3.52665330 |
44 | cotranslational protein targeting to membrane (GO:0006613) | 3.52390302 |
45 | respiratory electron transport chain (GO:0022904) | 3.51770544 |
46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.49767341 |
47 | negative regulation of ligase activity (GO:0051352) | 3.49767341 |
48 | response to topologically incorrect protein (GO:0035966) | 3.46587260 |
49 | cell redox homeostasis (GO:0045454) | 3.46531955 |
50 | endocrine pancreas development (GO:0031018) | 3.46512153 |
51 | electron transport chain (GO:0022900) | 3.42144215 |
52 | protein localization to endoplasmic reticulum (GO:0070972) | 3.39408772 |
53 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.38107652 |
54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.38041693 |
55 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.38006978 |
56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.37087197 |
57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.35811568 |
58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33427641 |
59 | mitochondrial calcium ion transport (GO:0006851) | 3.31389703 |
60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.31335237 |
61 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.31169587 |
62 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.30378874 |
63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.30378874 |
64 | oxidative phosphorylation (GO:0006119) | 3.30311120 |
65 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.25767038 |
66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.25767038 |
67 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.25767038 |
68 | respiratory burst (GO:0045730) | 3.24869035 |
69 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.23617024 |
70 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.23617024 |
71 | peptide hormone processing (GO:0016486) | 3.23367224 |
72 | vesicle coating (GO:0006901) | 3.22820133 |
73 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.22771810 |
74 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.22556681 |
75 | intestinal cholesterol absorption (GO:0030299) | 3.20731513 |
76 | DNA strand elongation (GO:0022616) | 3.17538280 |
77 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.16970472 |
78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.16736105 |
79 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.15618118 |
80 | chaperone-mediated protein transport (GO:0072321) | 3.14559366 |
81 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.13945422 |
82 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.11349579 |
83 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.11349579 |
84 | protein targeting to mitochondrion (GO:0006626) | 3.11187053 |
85 | neutrophil mediated immunity (GO:0002446) | 3.09516881 |
86 | positive regulation of ligase activity (GO:0051351) | 3.05231760 |
87 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.04743979 |
88 | reactive oxygen species biosynthetic process (GO:1903409) | 3.03667793 |
89 | 4-hydroxyproline metabolic process (GO:0019471) | 3.02913467 |
90 | deoxyribonucleotide catabolic process (GO:0009264) | 2.99370351 |
91 | maturation of SSU-rRNA (GO:0030490) | 2.97732433 |
92 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.96047201 |
93 | ribosome biogenesis (GO:0042254) | 2.95608897 |
94 | maintenance of protein localization in organelle (GO:0072595) | 2.93841547 |
95 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.92568585 |
96 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.91185772 |
97 | viral transcription (GO:0019083) | 2.90693359 |
98 | rRNA modification (GO:0000154) | 2.90506817 |
99 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.89551721 |
100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88878035 |
101 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88407466 |
102 | pentose metabolic process (GO:0019321) | 2.87314136 |
103 | deoxyribose phosphate catabolic process (GO:0046386) | 2.84839492 |
104 | negative regulation of B cell apoptotic process (GO:0002903) | 2.84671394 |
105 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.84443086 |
106 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.83943317 |
107 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.81223211 |
108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79017815 |
109 | cellular component biogenesis (GO:0044085) | 2.78610750 |
110 | regulation of cellular amine metabolic process (GO:0033238) | 2.78019909 |
111 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.77369914 |
112 | DNA replication checkpoint (GO:0000076) | 2.76388534 |
113 | protein autoprocessing (GO:0016540) | 2.76258083 |
114 | regulation of ligase activity (GO:0051340) | 2.76168036 |
115 | translational termination (GO:0006415) | 2.73020948 |
116 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.71263394 |
117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.71189437 |
118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.71189437 |
119 | NADH dehydrogenase complex assembly (GO:0010257) | 2.71189437 |
120 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.70461303 |
121 | protein complex biogenesis (GO:0070271) | 2.69626801 |
122 | translation (GO:0006412) | 2.69470857 |
123 | positive regulation of cell cycle arrest (GO:0071158) | 2.67470508 |
124 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67305706 |
125 | cellular response to interferon-beta (GO:0035458) | 2.66833007 |
126 | response to interferon-beta (GO:0035456) | 2.66718245 |
127 | neutrophil activation involved in immune response (GO:0002283) | 2.66285156 |
128 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.65887679 |
129 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.65314856 |
130 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.64530302 |
131 | nuclear envelope reassembly (GO:0031468) | 2.64508111 |
132 | mitotic nuclear envelope reassembly (GO:0007084) | 2.64508111 |
133 | protein localization to mitochondrion (GO:0070585) | 2.63815150 |
134 | pentose-phosphate shunt (GO:0006098) | 2.63392095 |
135 | ribosomal large subunit biogenesis (GO:0042273) | 2.62939830 |
136 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.62709449 |
137 | formation of translation preinitiation complex (GO:0001731) | 2.62158835 |
138 | translational elongation (GO:0006414) | 2.61997029 |
139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.61906924 |
140 | deoxyribose phosphate metabolic process (GO:0019692) | 2.61861270 |
141 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.61125125 |
142 | chaperone-mediated protein folding (GO:0061077) | 2.61029629 |
143 | peptide catabolic process (GO:0043171) | 2.60130430 |
144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.59674274 |
145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59156470 |
146 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.58509712 |
147 | glandular epithelial cell differentiation (GO:0002067) | 2.57266838 |
148 | valine metabolic process (GO:0006573) | 2.54759276 |
149 | proline metabolic process (GO:0006560) | 2.52461265 |
150 | nucleotide-sugar metabolic process (GO:0009225) | 2.52056672 |
151 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.45588453 |
152 | myeloid leukocyte mediated immunity (GO:0002444) | 2.44864690 |
153 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.44396305 |
154 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.42959578 |
155 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.42959578 |
156 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42073849 |
157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39748184 |
158 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.39593178 |
159 | apoptotic cell clearance (GO:0043277) | 2.39567196 |
160 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.38801031 |
161 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.38801031 |
162 | regulation of growth of symbiont in host (GO:0044126) | 2.38801031 |
163 | negative regulation of growth of symbiont in host (GO:0044130) | 2.38801031 |
164 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.37791701 |
165 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.37481028 |
166 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.37092289 |
167 | tetrahydrofolate metabolic process (GO:0046653) | 2.34599529 |
168 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.33130165 |
169 | killing of cells of other organism (GO:0031640) | 2.33002570 |
170 | disruption of cells of other organism (GO:0044364) | 2.33002570 |
171 | protein targeting to membrane (GO:0006612) | 2.32845400 |
172 | response to peptidoglycan (GO:0032494) | 2.32218467 |
173 | ribosomal small subunit assembly (GO:0000028) | 2.32165926 |
174 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.30870005 |
175 | NADPH regeneration (GO:0006740) | 2.28972979 |
176 | Golgi organization (GO:0007030) | 2.28466557 |
177 | maternal placenta development (GO:0001893) | 2.28392027 |
178 | response to fungus (GO:0009620) | 2.27959008 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.76380900 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.75473288 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.21988525 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05848954 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.91772138 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.65605691 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.60703490 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.58098475 |
9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.40822305 |
10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35515598 |
11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.33270738 |
12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.21041524 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11104517 |
14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10211285 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.10082742 |
16 | MYC_22102868_ChIP-Seq_BL_Human | 2.08392890 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01590946 |
18 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01527643 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99443263 |
20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99270946 |
21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.96557634 |
22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96386118 |
23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.95032455 |
24 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94650488 |
25 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.94460803 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92430062 |
27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90031274 |
28 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.85747508 |
29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85315071 |
30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84014777 |
31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82716260 |
32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81917129 |
33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81508269 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80909785 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79515249 |
36 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.77721250 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73619491 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72582400 |
39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70119613 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69829423 |
41 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68790126 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67865509 |
43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67365666 |
44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67244418 |
45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65065265 |
46 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.57435528 |
47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53944247 |
48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53638504 |
49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.51653296 |
50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.50824837 |
51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50661617 |
52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49060309 |
53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48708093 |
54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47654460 |
55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.46849062 |
56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.46605565 |
57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.45656255 |
58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45185111 |
59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43729341 |
60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43551929 |
61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43243348 |
62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42871586 |
63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.42775648 |
64 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42380256 |
65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41703573 |
66 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40946010 |
67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40183021 |
68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37872808 |
69 | MYB_26560356_Chip-Seq_TH2_Human | 1.34715650 |
70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34006443 |
71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33578071 |
72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33431350 |
73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32898710 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32851889 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32110424 |
76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32011278 |
77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31430568 |
78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29539295 |
79 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.29135242 |
80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28654132 |
81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28638324 |
82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27489000 |
83 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26156490 |
84 | P68_20966046_ChIP-Seq_HELA_Human | 1.25870008 |
85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25179599 |
86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23850695 |
87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.22869344 |
88 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.22769675 |
89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22040762 |
90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21195489 |
91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19717603 |
92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.19284504 |
93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18903957 |
94 | MYB_26560356_Chip-Seq_TH1_Human | 1.18672008 |
95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18610168 |
96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18369855 |
97 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17854603 |
98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16831173 |
99 | MAF_26560356_Chip-Seq_TH2_Human | 1.16671953 |
100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15866332 |
101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15409505 |
102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14949813 |
103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14682333 |
104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12269298 |
105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11840670 |
106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10765539 |
107 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10023700 |
108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09882302 |
109 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09749511 |
110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09162622 |
111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08847739 |
112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08252148 |
113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07768978 |
114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07552590 |
115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07373918 |
116 | MAF_26560356_Chip-Seq_TH1_Human | 1.07127718 |
117 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07060451 |
118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06357267 |
119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05905285 |
120 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.05864828 |
121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04823719 |
122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04757490 |
123 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02998158 |
124 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02585435 |
125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02301855 |
126 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01096706 |
127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01013122 |
128 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00692920 |
129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00033047 |
130 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99334854 |
131 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97267918 |
132 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97053506 |
133 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96514648 |
134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95878349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005220_abnormal_exocrine_pancreas | 3.40996859 |
2 | MP0005451_abnormal_body_composition | 3.35041630 |
3 | MP0002693_abnormal_pancreas_physiology | 3.01338242 |
4 | MP0003693_abnormal_embryo_hatching | 2.91100926 |
5 | MP0002877_abnormal_melanocyte_morpholog | 2.76362547 |
6 | MP0003183_abnormal_peptide_metabolism | 2.60004680 |
7 | MP0001835_abnormal_antigen_presentation | 2.55071562 |
8 | MP0005058_abnormal_lysosome_morphology | 2.55036666 |
9 | MP0001944_abnormal_pancreas_morphology | 2.42957483 |
10 | MP0003436_decreased_susceptibility_to | 2.38967561 |
11 | MP0001666_abnormal_nutrient_absorption | 2.37633138 |
12 | MP0003786_premature_aging | 2.37395330 |
13 | MP0005365_abnormal_bile_salt | 2.36759832 |
14 | MP0005083_abnormal_biliary_tract | 2.35407666 |
15 | MP0003111_abnormal_nucleus_morphology | 2.30856990 |
16 | MP0006054_spinal_hemorrhage | 1.93745024 |
17 | MP0002139_abnormal_hepatobiliary_system | 1.91379144 |
18 | MP0003300_gastrointestinal_ulcer | 1.91138017 |
19 | MP0004264_abnormal_extraembryonic_tissu | 1.87213146 |
20 | MP0005671_abnormal_response_to | 1.86936147 |
21 | MP0005000_abnormal_immune_tolerance | 1.85014053 |
22 | MP0003195_calcinosis | 1.84511754 |
23 | MP0003172_abnormal_lysosome_physiology | 1.81488747 |
24 | MP0008007_abnormal_cellular_replicative | 1.79385492 |
25 | MP0005025_abnormal_response_to | 1.77267408 |
26 | MP0004043_abnormal_pH_regulation | 1.77188113 |
27 | MP0010094_abnormal_chromosome_stability | 1.75586212 |
28 | MP0002419_abnormal_innate_immunity | 1.75180374 |
29 | MP0005310_abnormal_salivary_gland | 1.74951037 |
30 | MP0009840_abnormal_foam_cell | 1.74866350 |
31 | MP0003303_peritoneal_inflammation | 1.73061793 |
32 | MP0002132_abnormal_respiratory_system | 1.72817942 |
33 | MP0006035_abnormal_mitochondrial_morpho | 1.72240937 |
34 | MP0000343_altered_response_to | 1.65361846 |
35 | MP0000685_abnormal_immune_system | 1.63881086 |
36 | MP0001845_abnormal_inflammatory_respons | 1.63784560 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.62400661 |
38 | MP0009785_altered_susceptibility_to | 1.60479401 |
39 | MP0003077_abnormal_cell_cycle | 1.60461108 |
40 | MP0001790_abnormal_immune_system | 1.60138344 |
41 | MP0005387_immune_system_phenotype | 1.60138344 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.59915193 |
43 | MP0001545_abnormal_hematopoietic_system | 1.59915193 |
44 | MP0009643_abnormal_urine_homeostasis | 1.57926203 |
45 | MP0002166_altered_tumor_susceptibility | 1.57271278 |
46 | MP0008932_abnormal_embryonic_tissue | 1.56580538 |
47 | MP0001727_abnormal_embryo_implantation | 1.55782409 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.55303686 |
49 | MP0003283_abnormal_digestive_organ | 1.54282001 |
50 | MP0003724_increased_susceptibility_to | 1.54002841 |
51 | MP0002723_abnormal_immune_serum | 1.52410651 |
52 | MP0000490_abnormal_crypts_of | 1.50345354 |
53 | MP0004147_increased_porphyrin_level | 1.50276583 |
54 | MP0001800_abnormal_humoral_immune | 1.46559358 |
55 | MP0002452_abnormal_antigen_presenting | 1.46361624 |
56 | MP0002420_abnormal_adaptive_immunity | 1.46095380 |
57 | MP0001819_abnormal_immune_cell | 1.44184314 |
58 | MP0005464_abnormal_platelet_physiology | 1.44004537 |
59 | MP0001661_extended_life_span | 1.40284386 |
60 | MP0003186_abnormal_redox_activity | 1.36285580 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.35562538 |
62 | MP0003866_abnormal_defecation | 1.35287582 |
63 | MP0002078_abnormal_glucose_homeostasis | 1.35219435 |
64 | MP0003763_abnormal_thymus_physiology | 1.35007738 |
65 | MP0000678_abnormal_parathyroid_gland | 1.33054551 |
66 | MP0008469_abnormal_protein_level | 1.31379470 |
67 | MP0003868_abnormal_feces_composition | 1.30683934 |
68 | MP0000858_altered_metastatic_potential | 1.28414328 |
69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26886541 |
70 | MP0010155_abnormal_intestine_physiology | 1.26349468 |
71 | MP0000313_abnormal_cell_death | 1.26218440 |
72 | MP0005360_urolithiasis | 1.25452698 |
73 | MP0009278_abnormal_bone_marrow | 1.24247197 |
74 | MP0010386_abnormal_urinary_bladder | 1.23880946 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 1.23706786 |
76 | MP0005379_endocrine/exocrine_gland_phen | 1.22764604 |
77 | MP0002405_respiratory_system_inflammati | 1.21838643 |
78 | MP0001533_abnormal_skeleton_physiology | 1.21669870 |
79 | MP0006082_CNS_inflammation | 1.19092991 |
80 | MP0000716_abnormal_immune_system | 1.19035296 |
81 | MP0002398_abnormal_bone_marrow | 1.18159121 |
82 | MP0009697_abnormal_copulation | 1.16812573 |
83 | MP0002006_tumorigenesis | 1.16382939 |
84 | MP0004782_abnormal_surfactant_physiolog | 1.15199526 |
85 | MP0000613_abnormal_salivary_gland | 1.14085032 |
86 | MP0009379_abnormal_foot_pigmentation | 1.13325822 |
87 | MP0002928_abnormal_bile_duct | 1.12660197 |
88 | MP0005636_abnormal_mineral_homeostasis | 1.11589286 |
89 | MP0004947_skin_inflammation | 1.11339186 |
90 | MP0001873_stomach_inflammation | 1.11290169 |
91 | MP0000609_abnormal_liver_physiology | 1.09731129 |
92 | MP0003075_altered_response_to | 1.09573556 |
93 | MP0005084_abnormal_gallbladder_morpholo | 1.07537831 |
94 | MP0009764_decreased_sensitivity_to | 1.07300520 |
95 | MP0002429_abnormal_blood_cell | 1.07178901 |
96 | MP0000703_abnormal_thymus_morphology | 1.06054404 |
97 | MP0002396_abnormal_hematopoietic_system | 1.05578746 |
98 | MP0000689_abnormal_spleen_morphology | 1.05530290 |
99 | MP0001881_abnormal_mammary_gland | 1.04773551 |
100 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04202573 |
101 | MP0003718_maternal_effect | 1.03808008 |
102 | MP0005410_abnormal_fertilization | 1.03652748 |
103 | MP0005076_abnormal_cell_differentiation | 1.02429966 |
104 | MP0002909_abnormal_adrenal_gland | 1.01651986 |
105 | MP0005085_abnormal_gallbladder_physiolo | 1.01517890 |
106 | MP0002722_abnormal_immune_system | 1.00488598 |
107 | MP0001764_abnormal_homeostasis | 0.99325065 |
108 | MP0003191_abnormal_cellular_cholesterol | 0.98182856 |
109 | MP0003806_abnormal_nucleotide_metabolis | 0.97229707 |
110 | MP0002138_abnormal_hepatobiliary_system | 0.96103160 |
111 | MP0001765_abnormal_ion_homeostasis | 0.95985705 |
112 | MP0008260_abnormal_autophagy | 0.94694859 |
113 | MP0003959_abnormal_lean_body | 0.94333259 |
114 | MP0005408_hypopigmentation | 0.93608103 |
115 | MP0000598_abnormal_liver_morphology | 0.93596225 |
116 | MP0010307_abnormal_tumor_latency | 0.92273248 |
117 | MP0000681_abnormal_thyroid_gland | 0.91319628 |
118 | MP0001730_embryonic_growth_arrest | 0.90815153 |
119 | MP0005319_abnormal_enzyme/_coenzyme | 0.90109395 |
120 | MP0000465_gastrointestinal_hemorrhage | 0.89489846 |
121 | MP0003795_abnormal_bone_structure | 0.88052397 |
122 | MP0005332_abnormal_amino_acid | 0.88048536 |
123 | MP0001853_heart_inflammation | 0.87428566 |
124 | MP0005330_cardiomyopathy | 0.84846749 |
125 | MP0005165_increased_susceptibility_to | 0.84654621 |
126 | MP0003252_abnormal_bile_duct | 0.83484887 |
127 | MP0002019_abnormal_tumor_incidence | 0.83006958 |
128 | MP0001756_abnormal_urination | 0.82942871 |
129 | MP0008058_abnormal_DNA_repair | 0.82429377 |
130 | MP0000350_abnormal_cell_proliferation | 0.81547735 |
131 | MP0010352_gastrointestinal_tract_polyps | 0.81247277 |
132 | MP0004185_abnormal_adipocyte_glucose | 0.80443592 |
133 | MP0004510_myositis | 0.80059276 |
134 | MP0005501_abnormal_skin_physiology | 0.79122195 |
135 | MP0006036_abnormal_mitochondrial_physio | 0.78558724 |
136 | MP0008995_early_reproductive_senescence | 0.78292230 |
137 | MP0000358_abnormal_cell_content/ | 0.77795684 |
138 | MP0000372_irregular_coat_pigmentation | 0.77773652 |
139 | MP0009642_abnormal_blood_homeostasis | 0.77321420 |
140 | MP0009763_increased_sensitivity_to | 0.76215581 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 4.71788728 |
2 | Vacuolated lymphocytes (HP:0001922) | 4.48824106 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.44904088 |
4 | Hypoglycemic seizures (HP:0002173) | 4.36464000 |
5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.31754801 |
6 | Acute necrotizing encephalopathy (HP:0006965) | 4.25880502 |
7 | Dysostosis multiplex (HP:0000943) | 4.09391553 |
8 | Hyperthyroidism (HP:0000836) | 4.06711658 |
9 | Abnormal protein glycosylation (HP:0012346) | 4.01189067 |
10 | Abnormal glycosylation (HP:0012345) | 4.01189067 |
11 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.01189067 |
12 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.01189067 |
13 | Type I transferrin isoform profile (HP:0003642) | 3.95367895 |
14 | Acute encephalopathy (HP:0006846) | 3.92289200 |
15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.88417607 |
16 | Mucopolysacchariduria (HP:0008155) | 3.88417607 |
17 | Hypertensive crisis (HP:0100735) | 3.83645329 |
18 | Mitochondrial inheritance (HP:0001427) | 3.77148975 |
19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.76337425 |
20 | Symptomatic seizures (HP:0011145) | 3.69157950 |
21 | Increased CSF lactate (HP:0002490) | 3.54996061 |
22 | Truncus arteriosus (HP:0001660) | 3.52579282 |
23 | Reduced antithrombin III activity (HP:0001976) | 3.50472811 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.50280891 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.50280891 |
26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.50280891 |
27 | Hepatocellular necrosis (HP:0001404) | 3.46605321 |
28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.42023673 |
29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.42023673 |
30 | Thrombocytosis (HP:0001894) | 3.36324934 |
31 | Late onset (HP:0003584) | 3.31810420 |
32 | Seborrheic dermatitis (HP:0001051) | 3.31458939 |
33 | Generalized aminoaciduria (HP:0002909) | 3.25054833 |
34 | Progressive macrocephaly (HP:0004481) | 3.23268710 |
35 | Hepatic necrosis (HP:0002605) | 3.23114497 |
36 | Increased intramyocellular lipid droplets (HP:0012240) | 3.19010427 |
37 | Eczematoid dermatitis (HP:0000976) | 3.16523557 |
38 | Recurrent abscess formation (HP:0002722) | 3.12190307 |
39 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.09890152 |
40 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.09890152 |
41 | Cholecystitis (HP:0001082) | 3.09792360 |
42 | Abnormal gallbladder physiology (HP:0012438) | 3.09792360 |
43 | Ragged-red muscle fibers (HP:0003200) | 3.07449532 |
44 | Increased muscle lipid content (HP:0009058) | 3.02199342 |
45 | Cerebral edema (HP:0002181) | 3.01227473 |
46 | Recurrent bacterial skin infections (HP:0005406) | 2.97288066 |
47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89154314 |
48 | Abnormality of T cell physiology (HP:0011840) | 2.86419056 |
49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.82882491 |
50 | Rough bone trabeculation (HP:0100670) | 2.78200980 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76455648 |
52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74815286 |
53 | Neoplasm of head and neck (HP:0012288) | 2.73968767 |
54 | Esophageal neoplasm (HP:0100751) | 2.73968767 |
55 | Renal Fanconi syndrome (HP:0001994) | 2.72420850 |
56 | Ketoacidosis (HP:0001993) | 2.69691757 |
57 | Lactic acidosis (HP:0003128) | 2.67380392 |
58 | Increased serum lactate (HP:0002151) | 2.61603560 |
59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55418598 |
60 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.55373820 |
61 | Hypokinesia (HP:0002375) | 2.55201399 |
62 | Poor head control (HP:0002421) | 2.54328181 |
63 | Progressive neurologic deterioration (HP:0002344) | 2.51330396 |
64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.49573319 |
65 | Aplastic anemia (HP:0001915) | 2.49503617 |
66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47286955 |
67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47286955 |
68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47286955 |
69 | Exercise intolerance (HP:0003546) | 2.46148972 |
70 | IgM deficiency (HP:0002850) | 2.46004927 |
71 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45684452 |
72 | Thoracolumbar scoliosis (HP:0002944) | 2.44430401 |
73 | Abnormality of the tricuspid valve (HP:0001702) | 2.44164831 |
74 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.43821613 |
75 | Respiratory failure (HP:0002878) | 2.42019538 |
76 | Degeneration of anterior horn cells (HP:0002398) | 2.38272766 |
77 | Abnormality of the anterior horn cell (HP:0006802) | 2.38272766 |
78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.37152372 |
79 | Recurrent viral infections (HP:0004429) | 2.36694754 |
80 | Nonimmune hydrops fetalis (HP:0001790) | 2.36655077 |
81 | Pancytopenia (HP:0001876) | 2.34271599 |
82 | Testicular atrophy (HP:0000029) | 2.33891693 |
83 | Hypoparathyroidism (HP:0000829) | 2.28720825 |
84 | Increased serum pyruvate (HP:0003542) | 2.28670823 |
85 | Abnormality of glycolysis (HP:0004366) | 2.26704464 |
86 | Abnormality of macrophages (HP:0004311) | 2.26563443 |
87 | Ketosis (HP:0001946) | 2.26282258 |
88 | Increased serum ferritin (HP:0003281) | 2.24722148 |
89 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.23825648 |
90 | Abnormal trabecular bone morphology (HP:0100671) | 2.23637067 |
91 | Reticulocytopenia (HP:0001896) | 2.22530631 |
92 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.21986608 |
93 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21929698 |
94 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.20004013 |
95 | Chronic otitis media (HP:0000389) | 2.18694032 |
96 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.17234907 |
97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16369813 |
98 | Dicarboxylic aciduria (HP:0003215) | 2.16369813 |
99 | Progressive muscle weakness (HP:0003323) | 2.12261343 |
100 | Abnormality of reticulocytes (HP:0004312) | 2.12219812 |
101 | Hyperglycemia (HP:0003074) | 2.11789488 |
102 | Microvesicular hepatic steatosis (HP:0001414) | 2.11641495 |
103 | Large for gestational age (HP:0001520) | 2.11512868 |
104 | Insulin resistance (HP:0000855) | 2.09217522 |
105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08928387 |
106 | Reticulocytosis (HP:0001923) | 2.07335740 |
107 | Exocrine pancreatic insufficiency (HP:0001738) | 2.06266577 |
108 | Periodontitis (HP:0000704) | 2.06253553 |
109 | Increased cerebral lipofuscin (HP:0011813) | 2.05901005 |
110 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.04684887 |
111 | Beaking of vertebral bodies (HP:0004568) | 2.03538223 |
112 | Systemic lupus erythematosus (HP:0002725) | 2.03053735 |
113 | Lethargy (HP:0001254) | 2.02793982 |
114 | Respiratory difficulties (HP:0002880) | 2.01941641 |
115 | Petechiae (HP:0000967) | 2.01907248 |
116 | Atelectasis (HP:0100750) | 2.00598539 |
117 | Abnormal pancreas size (HP:0012094) | 2.00527603 |
118 | Joint stiffness (HP:0001387) | 1.99169351 |
119 | Abnormality of T cells (HP:0002843) | 1.98791330 |
120 | Emotional lability (HP:0000712) | 1.98703864 |
121 | Pancreatitis (HP:0001733) | 1.97911064 |
122 | Recurrent bronchitis (HP:0002837) | 1.96733489 |
123 | Fat malabsorption (HP:0002630) | 1.96382662 |
124 | Interstitial pulmonary disease (HP:0006530) | 1.95266933 |
125 | Villous atrophy (HP:0011473) | 1.94936479 |
126 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.94936479 |
127 | Nasal polyposis (HP:0100582) | 1.94625944 |
128 | Meningitis (HP:0001287) | 1.94449646 |
129 | Abnormality of the thoracic spine (HP:0100711) | 1.92893151 |
130 | Pallor (HP:0000980) | 1.92803966 |
131 | Oral leukoplakia (HP:0002745) | 1.89914007 |
132 | Recurrent skin infections (HP:0001581) | 1.89846056 |
133 | Microretrognathia (HP:0000308) | 1.89213102 |
134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88421130 |
135 | Nausea (HP:0002018) | 1.87935620 |
136 | Spastic paraparesis (HP:0002313) | 1.87427035 |
137 | Limb hypertonia (HP:0002509) | 1.87407331 |
138 | Thoracic kyphosis (HP:0002942) | 1.85660705 |
139 | Progressive microcephaly (HP:0000253) | 1.84274266 |
140 | Steatorrhea (HP:0002570) | 1.84245859 |
141 | Abdominal distention (HP:0003270) | 1.83488925 |
142 | Increased IgM level (HP:0003496) | 1.82678770 |
143 | Menorrhagia (HP:0000132) | 1.82528730 |
144 | Hepatosplenomegaly (HP:0001433) | 1.82196639 |
145 | Gastrointestinal inflammation (HP:0004386) | 1.82005107 |
146 | Obstructive lung disease (HP:0006536) | 1.81972163 |
147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81972163 |
148 | B lymphocytopenia (HP:0010976) | 1.81564461 |
149 | Abnormality of B cell number (HP:0010975) | 1.81564461 |
150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81478086 |
151 | Cholelithiasis (HP:0001081) | 1.81399499 |
152 | Redundant skin (HP:0001582) | 1.79821018 |
153 | Cellulitis (HP:0100658) | 1.78436960 |
154 | Abnormal number of erythroid precursors (HP:0012131) | 1.78180483 |
155 | Pustule (HP:0200039) | 1.76986697 |
156 | Multiple enchondromatosis (HP:0005701) | 1.76946073 |
157 | Macrocytic anemia (HP:0001972) | 1.76860827 |
158 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76287521 |
159 | Elevated alkaline phosphatase (HP:0003155) | 1.76194527 |
160 | Prominent metopic ridge (HP:0005487) | 1.76167892 |
161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76019396 |
162 | Abnormal large intestine physiology (HP:0012700) | 1.74870243 |
163 | Prolonged neonatal jaundice (HP:0006579) | 1.73880172 |
164 | Recurrent fungal infections (HP:0002841) | 1.73869089 |
165 | Myositis (HP:0100614) | 1.73760940 |
166 | Gout (HP:0001997) | 1.73535102 |
167 | Impaired platelet aggregation (HP:0003540) | 1.73407600 |
168 | Abnormal platelet function (HP:0011869) | 1.73407600 |
169 | Ileus (HP:0002595) | 1.73066192 |
170 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72875457 |
171 | Gingivitis (HP:0000230) | 1.71700820 |
172 | Type I diabetes mellitus (HP:0100651) | 1.71337025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 6.40604495 |
2 | EIF2AK3 | 3.82808485 |
3 | PASK | 3.57722224 |
4 | VRK2 | 3.25739854 |
5 | BCKDK | 3.11024218 |
6 | TAOK3 | 2.89978780 |
7 | INSRR | 2.76664301 |
8 | FLT3 | 2.70821005 |
9 | SCYL2 | 2.64145406 |
10 | IRAK3 | 2.45027513 |
11 | NME2 | 2.31972157 |
12 | IRAK4 | 2.28840771 |
13 | MAP4K1 | 2.01403652 |
14 | SMG1 | 1.95520971 |
15 | NME1 | 1.95065457 |
16 | TESK2 | 1.68205547 |
17 | MAPK15 | 1.60207528 |
18 | TYK2 | 1.59420691 |
19 | HIPK2 | 1.58629781 |
20 | JAK3 | 1.58534433 |
21 | PIM2 | 1.58417777 |
22 | STK16 | 1.57528719 |
23 | ZAP70 | 1.56114922 |
24 | TBK1 | 1.55225236 |
25 | TESK1 | 1.55054638 |
26 | CLK1 | 1.40548516 |
27 | PBK | 1.40509266 |
28 | TEC | 1.37388418 |
29 | PDK2 | 1.36639089 |
30 | BTK | 1.36620768 |
31 | LIMK1 | 1.34028742 |
32 | BLK | 1.32400915 |
33 | TRIB3 | 1.21592137 |
34 | MAP3K14 | 1.19355270 |
35 | TAOK2 | 1.17936340 |
36 | BRSK2 | 1.17664422 |
37 | PKN2 | 1.13391356 |
38 | EIF2AK1 | 1.12920111 |
39 | AURKA | 1.11091528 |
40 | KDR | 1.08139063 |
41 | SRPK1 | 1.05796404 |
42 | RPS6KA4 | 1.04108842 |
43 | FRK | 1.04089807 |
44 | NEK1 | 1.02574622 |
45 | EEF2K | 1.01815234 |
46 | KIT | 1.01641758 |
47 | MAP2K2 | 0.99792155 |
48 | VRK1 | 0.95945280 |
49 | SYK | 0.95776835 |
50 | ILK | 0.95497213 |
51 | MAPKAPK3 | 0.95250816 |
52 | EPHA2 | 0.95061003 |
53 | IKBKE | 0.92623568 |
54 | PAK1 | 0.89192903 |
55 | BRAF | 0.87340630 |
56 | WEE1 | 0.86332637 |
57 | BUB1 | 0.84140297 |
58 | MAP3K10 | 0.83427010 |
59 | CAMKK2 | 0.81463422 |
60 | ITK | 0.80640634 |
61 | RAF1 | 0.79732220 |
62 | LYN | 0.78434824 |
63 | CHEK2 | 0.78197492 |
64 | PIM1 | 0.77697645 |
65 | MAP3K12 | 0.77429905 |
66 | TTK | 0.76936026 |
67 | MAP3K1 | 0.76342364 |
68 | DYRK3 | 0.76308979 |
69 | ACVR1B | 0.76125010 |
70 | RPS6KA5 | 0.76045949 |
71 | JAK2 | 0.74354800 |
72 | STK4 | 0.73779633 |
73 | CSK | 0.73763611 |
74 | DAPK1 | 0.73254822 |
75 | CSF1R | 0.71707548 |
76 | IKBKB | 0.71437675 |
77 | JAK1 | 0.71241972 |
78 | NEK2 | 0.70077099 |
79 | DYRK1B | 0.69602172 |
80 | PIK3CG | 0.68385589 |
81 | DAPK3 | 0.68141213 |
82 | MAP3K11 | 0.68050625 |
83 | IRAK1 | 0.65451215 |
84 | LRRK2 | 0.64986782 |
85 | MAP3K2 | 0.64512424 |
86 | SIK1 | 0.64347730 |
87 | MAP2K3 | 0.63021984 |
88 | NLK | 0.62173798 |
89 | CCNB1 | 0.59203229 |
90 | CHUK | 0.58331833 |
91 | MAP3K3 | 0.56631585 |
92 | RPS6KB2 | 0.56574421 |
93 | ICK | 0.56015199 |
94 | IRAK2 | 0.55586190 |
95 | MAP3K8 | 0.55044957 |
96 | ARAF | 0.54104104 |
97 | PTK6 | 0.53488115 |
98 | STK10 | 0.52920882 |
99 | EPHA3 | 0.52896802 |
100 | CSNK1G3 | 0.52311685 |
101 | ZAK | 0.51671399 |
102 | CDC7 | 0.51594813 |
103 | EIF2AK2 | 0.51063954 |
104 | ATR | 0.46810590 |
105 | LCK | 0.46749886 |
106 | TLK1 | 0.46442756 |
107 | GRK6 | 0.45332362 |
108 | ABL2 | 0.43440008 |
109 | MAP2K6 | 0.43118743 |
110 | CSNK2A1 | 0.42879043 |
111 | TSSK6 | 0.42357106 |
112 | CSNK2A2 | 0.42025015 |
113 | PLK1 | 0.41671103 |
114 | PAK4 | 0.40545924 |
115 | RIPK4 | 0.40401091 |
116 | PRKG2 | 0.39298935 |
117 | BRSK1 | 0.39268177 |
118 | WNK4 | 0.38839159 |
119 | CDK8 | 0.38731224 |
120 | GRK7 | 0.38503634 |
121 | CDK7 | 0.38093613 |
122 | MST4 | 0.37840653 |
123 | CAMK2G | 0.37458624 |
124 | NEK9 | 0.37111765 |
125 | TXK | 0.36979703 |
126 | MAPKAPK5 | 0.36147990 |
127 | CHEK1 | 0.35897595 |
128 | MAPKAPK2 | 0.34917450 |
129 | MAPK11 | 0.34342850 |
130 | MST1R | 0.33918979 |
131 | PRKCI | 0.33798346 |
132 | AURKB | 0.31950595 |
133 | PLK4 | 0.31924830 |
134 | PRKCD | 0.31791737 |
135 | CSNK1A1L | 0.31774105 |
136 | MATK | 0.31633711 |
137 | CDK4 | 0.31022287 |
138 | RPS6KA6 | 0.30278989 |
139 | AKT2 | 0.28035382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 6.77758307 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.19212804 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.14036574 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.22918136 |
5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.88738125 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.78276762 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48712656 |
8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.29524149 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16432634 |
10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.15976523 |
11 | DNA replication_Homo sapiens_hsa03030 | 2.10839569 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03496111 |
13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91449307 |
14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86117465 |
15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78920100 |
16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.77113081 |
17 | Lysosome_Homo sapiens_hsa04142 | 1.75789649 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.62946013 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62197353 |
20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58513395 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.41202091 |
22 | Ribosome_Homo sapiens_hsa03010 | 1.37320373 |
23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36542268 |
24 | Proteasome_Homo sapiens_hsa03050 | 1.29368637 |
25 | Mismatch repair_Homo sapiens_hsa03430 | 1.28396182 |
26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26712964 |
27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25415773 |
28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24892645 |
29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.24562077 |
30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.21464608 |
31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20973424 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19302660 |
33 | Base excision repair_Homo sapiens_hsa03410 | 1.17558288 |
34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12740572 |
35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10881740 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09786625 |
37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08763082 |
38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06860201 |
39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06133375 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05344223 |
41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04357877 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01895307 |
43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97118931 |
44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95864192 |
45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94499139 |
46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88109005 |
47 | Shigellosis_Homo sapiens_hsa05131 | 0.85368162 |
48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84594724 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83595983 |
50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80999242 |
51 | Homologous recombination_Homo sapiens_hsa03440 | 0.79439831 |
52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78673408 |
53 | Allograft rejection_Homo sapiens_hsa05330 | 0.78262785 |
54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77195309 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75221878 |
56 | Pertussis_Homo sapiens_hsa05133 | 0.72505083 |
57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70366201 |
58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69996309 |
59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68501918 |
60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67661879 |
61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66792485 |
62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66514763 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66188042 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65945660 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65266014 |
66 | Measles_Homo sapiens_hsa05162 | 0.64423332 |
67 | Influenza A_Homo sapiens_hsa05164 | 0.64299480 |
68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64232965 |
69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63492879 |
70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62947858 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61790859 |
72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61257657 |
73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60592017 |
74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60192850 |
75 | Prion diseases_Homo sapiens_hsa05020 | 0.59952384 |
76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59825302 |
77 | Cell cycle_Homo sapiens_hsa04110 | 0.59770950 |
78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59342708 |
79 | RNA polymerase_Homo sapiens_hsa03020 | 0.58246419 |
80 | Salmonella infection_Homo sapiens_hsa05132 | 0.58169172 |
81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57704285 |
82 | Apoptosis_Homo sapiens_hsa04210 | 0.57684428 |
83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57068246 |
84 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56897084 |
85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56773106 |
86 | Phagosome_Homo sapiens_hsa04145 | 0.54360988 |
87 | Spliceosome_Homo sapiens_hsa03040 | 0.53855017 |
88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52987208 |
89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52052863 |
90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51919482 |
91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51044153 |
92 | Peroxisome_Homo sapiens_hsa04146 | 0.49345766 |
93 | Asthma_Homo sapiens_hsa05310 | 0.48977666 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48340409 |
95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48160914 |
96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47147297 |
97 | Bladder cancer_Homo sapiens_hsa05219 | 0.47052999 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46599595 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46537601 |
100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45071295 |
101 | Tuberculosis_Homo sapiens_hsa05152 | 0.44930688 |
102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42297008 |
103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41408834 |
104 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40906850 |
105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40344779 |
106 | RNA transport_Homo sapiens_hsa03013 | 0.39633233 |
107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39473771 |
108 | ABC transporters_Homo sapiens_hsa02010 | 0.38856455 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38392501 |
110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37961113 |
111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37634561 |
112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37107816 |
113 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.36997356 |
114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36250578 |
115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35041014 |
116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35012470 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34449189 |
118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34214881 |
119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33855303 |
120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32754611 |
121 | Hepatitis B_Homo sapiens_hsa05161 | 0.31570630 |
122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31170053 |
123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30416373 |
124 | Insulin resistance_Homo sapiens_hsa04931 | 0.29686341 |
125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29358872 |
126 | RNA degradation_Homo sapiens_hsa03018 | 0.28698617 |
127 | Purine metabolism_Homo sapiens_hsa00230 | 0.28452923 |
128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28434068 |
129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28154284 |
130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27602884 |
131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27597642 |
132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27149560 |